The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein
Open accessAbstract
Tau is a neuronal phosphoprotein the expression of which is developmentally regulated. A single tau isoform is expressed in fetal human brain but six isoforms are expressed in adult human brain, with the fetal isoform corresponding to the shortest adult isoform. Phosphorylation is also developmentally regulated, as fetal tau is phosphorylated at more sites than adult tau. In Alzheimer's disease, the six adult tau isoforms become hyperphosphorylated and form the paired helical filament (PHF), the major fibrous component of the neurofibrillary lesions. One way to identify phosphorylated sites in tau is to use antibodies that recognize phosphorylated residues within a specific amino acid sequence. We here characterize the two novel phosphorylation-dependent anti-tau antibodies AT270 and AT180 and identify their epitopes as containing phosphorylated Thr-181 and Thr-231 respectively. With these antibodies we show that these two threonine residues are partially phosphorylated in fetal and adult tau and almost fully phosphorylated in PHF tau. This result contrasts with previous studies of Ser-202 and Ser-396 which are partially phosphorylated in fetal tau, unphosphorylated in adult tau but almost fully phosphorylated in PHF tau.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“No significant differences in phospho-tau levels relative to controls were observed (Supplementary Material, Fig. S4).”
From Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation (2011) · cites this paper as [86]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Self-citationA68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Self-citationGoedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Self-citationGoedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037
Self-citationGoedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929
Self-citationBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–377 of 377
Ott, S., Henkel, A. W., Henkel, M. K., Redzic, Z. B., Kornhuber, J., & Wiltfang, J. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0671-7 · Cited by 13
Canet, G., Rocaboy, E., Laliberté, F., Boscher, E., Guisle, I., Diego-Diàz, S., Fereydouni-Forouzandeh, P., Whittington, R. A., Hébert, S. S., Pernet, V., et al. (2023) · Experimental Neurobiology · doi:10.5607/en23025 · Cited by 12
Morcinek, K., Köhler, C. N., Götz, J., & Schröder, H. (2012) · Brain Research · doi:10.1016/j.brainres.2012.12.016 · Cited by 11
Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy
Köhler, C. N., Bista, P., Götz, J., & Schröder, H. C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.076 · Cited by 11
Bondareff, W., Matsuyama, S. S., & Dell’Albani, P. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980601)52:5 · Cited by 11
Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients
Bellier, J., Cai, Y., Alam, S. M., Wiederhold, T., Aiello, A., Vogelgsang, J. S., Berretta, S., Chhatwal, J. P., Selkoe, D. J., & Liu, L. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13557 · Cited by 10
High-yield purification of fetal tau preserving its structure and phosphorylation pattern
Ivanovova, N. P., Handzusova, M., Hanes, J., Kontseková, E., & Novák, M. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.07.014 · Cited by 10
Davies, E. S., Morphew, R. M., Cutress, D. J., Morton, A. J., & McBride, S. D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04572-z · Cited by 9
Gandhi, N. S., Kukić, P., Lippens, G. M., & Mancera, R. L. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_3 · Cited by 9
Petry, F. R., Nicholls, S. B., Hébert, S. S., & Planel, E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_15 · Cited by 10
Kinase-loaded magnetic beads for sequential in vitro phosphorylation of peptides and proteins
Hromádková, L., Kupčík, R., Vajrychová, M., Přikryl, P., Charvátová, A., Jankovičová, B., Řı́pová, D., Bı́lková, Z., & Slováková, M. (2017) · The Analyst · doi:10.1039/c7an01508a · Cited by 9
Combs, C. K., Coleman, P. D., & O’Banion, M. K. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00019-4 · Cited by 9
Protein kinases involved in the phosphorylation of human tau protein in transfected COS-1 cells
Medina, M., Garcı́a-Rocha, M., Padilla, R., Pérez, M., de Garcini, E. M., & Ávila, J. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00018-x · Cited by 9
Xia, Y., Bell, B. M., Kim, J. D., & Giasson, B. I. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1181804 · Cited by 8
Bertrand, J., Sénéchal, P., Zummo‐Soucy, M., Plouffe, V., & Leclerc, N. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06855.x · Cited by 7
EGCG modulates nuclear formaldehyde-induced Tau phosphorylation in Neuronal cellsPreprint
Sonawane, S. K., Raina, A., Majumdar, A., & Chinnathambi, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.04.325134 · Cited by 7
Gazarian, K. G., Ramírez-García, L. R., Orozco, L. T., Luna‐Muñoz, J., & Pacheco‐Herrero, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.612657 · Cited by 6
Simultaneous detection of tau phospho-epitopes with haptenylated antibodies
Härtig, W., Lehmann, J., Stieler, J., Singer, D. L., Grosche, J., Arendt, T., & Hoffmann, R. (2006) · Neuroreport · doi:10.1097/01.wnr.0000215778.76602.da · Cited by 6
Tau in Multiple Sclerosis: A Review of Therapeutic Potential
Hoehne, C. L., Stüve, O., & Stopschinski, B. E. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-024-00820-8 · Cited by 6
Homogeneous Femtomolar Detection of P-tau181 via Proximity Extension and CRISPR/Cas Technique
Liu, H., Liu, Y., Feng, R., Qian, M., Li, Y., Zhai, S., Song, J., & Qiu, X. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c04856 · Cited by 7
Tau Phosphorylation Both In Vitro and in Cells
Reynolds, C. H., Gibb, G., & Lovestone, S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-195-7:375 · Cited by 4
Deregulation of Cytoskeletal Protein Phosphorylation and Neurodegeneration
Kanungo, J., Zheng, Y.-L., Rudrabhatla, P., Amin, N. D., Mishra, B., & Pant, H. C. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_14 · Cited by 4
Moloney, C. M., Rutledge, M. H., Labuzan, S. A., Peng, Z., Tranovich, J. F., Wood, A. C., Rothberg, D. M., Duara, R., Lachner, C., Graff‐Radford, N. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.02.657435 · Cited by 6
Shabana, S., Hamouda, H. I., Shang, A., Shao, S., Zhao, J., Yuan, H., & Liu, B. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01932-2 · Cited by 3
Canet, G., Gratuze, M., Zussy, C., Bouali, M. L., Diego-Diàz, S., Rocaboy, E., Laliberté, F., Khoury, N. B. E., Tremblay, C., Morin, F., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106526 · Cited by 3
NEURONAL FUNCTIONS OF PROTEIN PHOSPHATASE 2A
Leung, H. (2013) · Neuroscience International · doi:10.3844/amjnsp.2013.46.55 · Cited by 3
Ko, K. M., Leong, P. K., Lam, P. Y., & Chen, N. (2014) · The Open Nutraceuticals Journal · doi:10.2174/1876396001407010049 · Cited by 3
Influence of Phospholipids and Sequential Kinase Activities on Tau in Vitro
SHEA, T. B., & Ekinci, F. J. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4869-0_11 · Cited by 3
Ras target protein canoe is a substrate for Cdc2 and Cdk5 kinases
Takahashi, K., Hamada, N., & Yamamoto, D. (2002) · Archives of Insect Biochemistry and Physiology · doi:10.1002/arch.10012 · Cited by 3
τ Protein and the Neurofibrillary Pathology of Alzheimer’s Disease
Goedert, M., Trojanowski, J. Q., & Lee, V. M. ‐. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_12 · Cited by 3
Self-citationTau protein aggregation: A therapeutic target for neurodegenerative diseases
Duggal, A., Mahindru, D., Baghel, K., Mehrotra, S., & Prajapati, V. K. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.11.012 · Cited by 2
A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies
Paterno, G., Bell, B. M., Gorion, K.-M. M., Quintin, S. S., Prokop, S., & Giasson, B. I. (2025) · Scientific Reports · doi:10.1038/s41598-025-04291-y · Cited by 2
Kano, M., 妙子, 木., Yanagisawa, H., Yamashita, K., Tatsumi, L., Sakai, A., Li, X., Saido, T. C., Saito, T., Takatori, S., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02407-7 · Cited by 2
Western Blot of Tau Protein from Mouse Brains Extracts: How to Avoid Signal Artifacts
Fereydouni-Forouzandeh, P., Canet, G., Diego-Diàz, S., Rocaboy, E., Petry, S., Whittington, R. A., & Planel, E. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3629-9_16 · Cited by 3
Correlation between tau phosphorylation sites and tangle morphology in Alzheimer's disease
Shimazaki, M., NAKANO, H., & Kobayashi, K. (2005) · Psychogeriatrics · doi:10.1111/j.1479-8301.2005.00087.x · Cited by 2
Tau-Centric Therapies for Treating Alzheimer’s Disease
Quraishe, S., Cowan, C. M., & Mudher, A. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00005-3 · Cited by 1
Alonso-Estanillo, B., Ochoa, M., Gómez, L., Pin, X., López, A., & Vásquez, F. (2026) · Biology · doi:10.3390/biology15110845 · Cited by 1
Widespread Brainstem Neurodegeneration in Huntington’s Disease (HD)
Rüb, U., Vonsattel, J. P., Heinsen, H., & Korf, H. (2015) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-19285-7_7 · Cited by 1
Molecular and Cellular Abnormalities of Tau in Early Alzheimer’s Disease
Davies, P., Weaver, C. L., & Jicha, G. A. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_2 · Cited by 1
Abnormal tau proteins and neuronal degeneration in Alzheimer's disease
Bondareff, W., & Matsuyama, S. S. (1995) · International Review of Psychiatry · doi:10.3109/09540269509022987 · Cited by 1
de Bioquímica, D., & de Psicología, D. (2007) · Cited by 1
Ronayne, R. E. (2008) · Digital WPI · Cited by 1
Hyperphosphorylation of Tau in Apolipoprotein E-Deficient Mice
Genis, I., & Michaelson, D. M. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_35 · Cited by 1
Tau Phosphorylation and Dephosphorylation in the Pathogenesis of Alzheimer’s Disease
Mawal-Dewan, M., Trojanowski, J. Q., & Lee, V. M.-Y. (1996) · Springer eBooks · doi:10.1007/978-3-662-03248-0_7 · Cited by 1
Duff, K., Krishnamurthy, P., Planel, E., & Hutton, M. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_13
Pseudophosphorylation of tau modulates its function and induces AD-like changes
Sun, Q. (2009) · KU ScholarWorks (The University of Kansas)
Vanderstichele, H., de Vreese, K., Blennow, K., Andreasen, N., Ivanoiu, A., Hampel, H. J., Parnetti, L., Padovani, A., Pottel, H., Hulstaert, F., et al. (2006)
Self-citationSeidel, K., den Dunnen, W. F. A., Schultz, C., Frank, S., Deller, T., Anatomy, S., Paulson, H. L., de Vos, R. A., Brunt, E. R. P., Kampinga, H. H., et al. (2010)
Butzlaff, M. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1007
Activation of glycogen synthase kinase 3β promotes the intermolecular association of tau.
Chun, W., & Johnson, G. V. W. (2007) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)58726-7
(2005) · FEBS Letters · doi:10.1016/s0014-5793(05)01501-2
Tau Protein and the Neurofibrillary Pathology of Alzheimer’s Disease
Goedert, M. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_9 · Cited by 1
Self-citationMathew, R., Srinivas, G. V., & Mathuranath, P. S. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_19
Molecular chaperone and chaperone-based therapeutic approaches for Alzheimer’s disease
Anand, T., & Kumar, A. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.11.006
Wilson, E. N., Young, C. B., Benitez, J. A. R., Swarovski, M. S., Feinstein, I., Vandijck, M. L. J., Guen, Y. L., Kasireddy, N. M., Shahid, M., Corso, N. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21547387
Wilson, E. N., Young, C. B., Benitez, J. A. R., Swarovski, M. S., Feinstein, I., Vandijck, M. L. J., Guen, Y. L., Kasireddy, N. M., Shahid, M., Corso, N. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21547393
Wilson, E. N., Young, C. B., Benitez, J. A. R., Swarovski, M. S., Feinstein, I., Vandijck, M. L. J., Guen, Y. L., Kasireddy, N. M., Shahid, M., Corso, N. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21547396
Wilson, E. N., Young, C. B., Benitez, J. A. R., Swarovski, M. S., Feinstein, I., Vandijck, M. L. J., Guen, Y. L., Kasireddy, N. M., Shahid, M., Corso, N. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21547390
Ennis, G. E., Betthauser, T. J., Koscik, R. L., Chin, N. A., Christian, B. T., Asthana, S., Johnson, S. C., & Bendlin, B. B. (2023) · Figshare · doi:10.6084/m9.figshare.22618903
Wilson, E. N., Young, C. B., Benitez, J. A. R., Swarovski, M. S., Feinstein, I., Vandijck, M. L. J., Guen, Y. L., Kasireddy, N. M., Shahid, M., Corso, N. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21547384
Additional file 1 of Synaptic tau: A pathological or physiological phenomenon?
Robbins, M., Clayton, E. L., & Schierle, G. S. K. (2021) · Figshare · doi:10.6084/m9.figshare.16599510
Regional correlates of tau pathology and synaptic function in primary age-related tauopathy
Kadamangudi, S., Sánchez-Sánchez, L., Limón, A., & Taglialatela, G. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261416524
Rôle des modifications post-traductionnelles dans le processus d’agrégation de la protéine Tau
Despres, C. (2017) · theses.fr (ABES) · doi:10.70675/de10f843z8572z4295zb672z763dbf30e2b5
Identification et caractérisation fonctionnelle de nouveaux sites de clivage de la protéine Tau
Derisbourg, M. J. (2015) · theses.fr (ABES) · doi:10.70675/ef5f45b0zf4e8z433fz9beaz8d2cc6de65bc
Siddique, I. A., Hong, M., & Bitan, G. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_189
BindingDB (2017) · UC San Diego · doi:10.7270/q2th8ph8
Metadata
- Authors
- Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelen, E., Vandermeeren, M., & Cras, P.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- University of Dundee (GB)
- Fujirebio (Belgium) (BE)
- University of Antwerp (BE)
- Corresponding author
- Goedert, M
- Jakes, R
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1994-08-01
- Volume
- 301
- Issue
- 3
- Pages
- 871-877
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1137067
- OpenAlex
- W1958842451
- Cited by
- 375
- References
- 51
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 4 · 2023: 5 · 2022: 12 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 7 · 2017: 10 · 2016: 7 · 2015: 8 · 2014: 8 · 2013: 9 · 2012: 13
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, paired helical filaments, Alzheimer's disease, epitope mapping, phosphorylation sites, neurofibrillary tangles, tau hyperphosphorylation
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antibody Specificity, Epitopes, Binding Sites, Brain, Brain Chemistry, Cerebral Cortex, Humans, Molecular Sequence Data, Phosphorylation, Phosphothreonine, Recombinant Proteins, Structure-Activity Relationship, Microscopy, Immunoelectron, Neurofibrillary Tangles, tau Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review